Mirtazapine

Chemical formula: C₁₇H₁₉N₃  Molecular mass: 265.353 g/mol  PubChem compound: 4205

Therapeutic indications

Mirtazapine is indicated for:

Episodes of major depression

Population group: only adults (18 years old or older)

Treatment of episodes of major depression.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Mirtazapine is contraindicated in the following cases:

Monoamine oxidase (MAO) inhibitors

Monoamine oxidase inhibitors (MAOIs)

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.